Blocking KCa1.1 with paxilline reduced normal myoblast migration to levels similar to those of DM1 myoblasts, whereas paxilline had no significant effect on DM1 myoblast migration (Figures 6a and b). The gene discussed is KCNMA1; the disease is myotonic dystrophy type 1.